Publication
Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)
| dc.contributor.author | Davies, K.A. | |
| dc.contributor.author | Longshaw, C.M. | |
| dc.contributor.author | Davis, G. | |
| dc.contributor.author | Bouza, E. | |
| dc.contributor.author | Barbut, F. | |
| dc.contributor.author | Barna, Z. | |
| dc.contributor.author | Delmée, M. | |
| dc.contributor.author | Fitzpatrick, F. | |
| dc.contributor.author | Ivanova, K. | |
| dc.contributor.author | Kuipjer, E. | |
| dc.contributor.author | Macovei, I.S. | |
| dc.contributor.author | Mentula, S. | |
| dc.contributor.author | Mastrantonio, P. | |
| dc.contributor.author | von Müller, L. | |
| dc.contributor.author | Oleastro, M. | |
| dc.contributor.author | Petinaki, E. | |
| dc.contributor.author | Pituch, H. | |
| dc.contributor.author | Norén, T. | |
| dc.contributor.author | Nováková, E. | |
| dc.contributor.author | Nyc, O. | |
| dc.contributor.author | Rupnik, M. | |
| dc.contributor.author | Schmid, D. | |
| dc.contributor.author | Wilcox, M.H. | |
| dc.date.accessioned | 2015-02-19T13:39:18Z | |
| dc.date.available | 2015-02-19T13:39:18Z | |
| dc.date.issued | 2014-12 | |
| dc.description | Comment in: Hidden burden of undiagnosed Clostridium difficile infection. [Lancet Infect Dis. 2014] | por |
| dc.description.abstract | BACKGROUND: Variations in testing for Clostridium difficile infection can hinder patients' care, increase the risk of transmission, and skew epidemiological data. We aimed to measure the underdiagnosis of C difficile infection across Europe. METHODS: We did a questionnaire-based study at 482 participating hospitals across 20 European countries. Hospitals were questioned about their methods and testing policy for C difficile infection during the periods September, 2011, to August, 2012, and September, 2012, to August, 2013. On one day in winter, 2012-13 (December, 2012, or January, 2013), and summer, 2013 (July or August), every hospital sent all diarrhoeal samples submitted to their microbiology laboratory to a national coordinating laboratory for standardised testing of C difficile infection. Our primary outcome measures were the rates of testing for and cases of C difficile infection per 10 000 patient bed-days. Results of local and national C difficile infection testing were compared with each other. If the result was positive at the national laboratory but negative at the local hospital, the result was classified as undiagnosed C difficile infection. We compared differences in proportions with the Mann-Whitney test, or McNemar's test if data were matched. FINDINGS: During the study period, participating hospitals reported a mean of 65·8 tests (country range 4·6-223·3) for C difficile infection per 10 000 patient-bed days and a mean of 7·0 cases (country range 0·7-28·7) of C difficile infection per 10 000 patient-bed days. Only two-fifths of hospitals reported using optimum methods for testing of C difficile infection (defined by European guidelines), although the number of participating hospitals using optimum methods increased during the study period, from 152 (32%) of 468 in 2011-12 to 205 (48%) of 428 in 2012-13. Across all 482 European hospitals on the two sampling days, 148 (23%) of 641 samples positive for C difficile infection (as determined by the national laboratory) were not diagnosed by participating hospitals because of an absence of clinical suspicion, equating to about 74 missed diagnoses per day. INTERPRETATION: A wide variety of testing strategies for C difficile infection are used across Europe. Absence of clinical suspicion and suboptimum laboratory diagnostic methods mean that an estimated 40 000 inpatients with C difficile infection are potentially undiagnosed every year in 482 European hospitals. | por |
| dc.description.sponsorship | Astellas Pharmaceuticals Europe | por |
| dc.identifier.citation | Lancet Infect Dis. 2014 Dec;14(12):1208-19. doi: 10.1016/S1473-3099(14)70991-0. Epub 2014 Nov 7 | por |
| dc.identifier.doi | 10.1016/S1473-3099(14)70991-0 | |
| dc.identifier.issn | 1473-3099 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/2921 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Elsevier | por |
| dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S1473309914709910 | por |
| dc.subject | Clostridium Difficile | por |
| dc.subject | Underdiagnosis | por |
| dc.subject | European Study | por |
| dc.subject | Infecções Gastrointestinais | por |
| dc.title | Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID) | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1219 | por |
| oaire.citation.startPage | 1208 | por |
| oaire.citation.title | Lancet Infectious Diseases | por |
| oaire.citation.volume | 14(12) | por |
| rcaap.rights | embargoedAccess | por |
| rcaap.type | article | por |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Underdiagnosis of Clostridium diffi cile across Europe_2014.pdf
- Size:
- 453.73 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
